Articles

The global Blood Clot Retrieval Devices Market is on a strong growth trajectory, expanding from USD 1.81 billion in 2024 to an anticipated USD 4.63 billion by 2033, at a robust CAGR of 11.1%, according to a recent report from Ameco Research. This surge is driven by rising incidences of ischemic stroke, an aging population, and the shift towards minimally invasive thrombectomy interventions. North America leads the market, whereas Asia-Pacific emerges as the fastest-growing region. Among the key technologies, stent retrievers and aspiration devices remain front-runners. Hospitals continue to dominate as the primary end-user segment, supported by advanced infrastructure and clinical expertise.
Stroke continues to be one of the leading causes of mortality and long-term disability worldwide. Wi…

The Systemic Mastocytosis Treatment Market is poised for steady growth, reaching USD 482.3 million by 2032 from USD 310.5 million in 2023, at a CAGR of 5.1%, according to Acumen Research and Consulting. Growth is driven by rising rare disease awareness, advancements in targeted therapies such as tyrosine kinase inhibitors, and supportive regulatory frameworks including orphan drug designations. North America currently leads due to strong healthcare infrastructure and rapid adoption of novel drugs, while Asia-Pacific is emerging as the fastest-growing region. Key players including Blueprint Medicines, Novartis, and AB Science are expanding pipelines through R&D and partnerships. Despite challenges such as high treatment costs and limited patient pools, innovation is steering the market toward transformative, patient-centric therapies.

The global Microcatheters Market is projected to reach USD 1.5 billion by 2032, growing at a CAGR of 7.7% from 2024–2032, according to Acumen Research and Consulting. The market is witnessing steady growth driven by the rising demand for minimally invasive procedures, increasing prevalence of cardiovascular and neurovascular diseases, and rapid advancements in microcatheter technologies. North America currently leads the market due to advanced healthcare infrastructure, while Asia-Pacific is expected to experience the fastest growth. This article explores key market trends, size, share, regional dynamics, and growth opportunities shaping the future of the Microcatheters Market.
The Microcatheters Market is undergoing rapid expansion, fuelled by the growing adoption of minimally invasive pro…

The Anti Stretch Mark Products Market is witnessing robust growth, fuelled by rising awareness around skincare, increasing demand among pregnant women, and expanding product innovations from global brands. According to Acumen Research and Consulting, the market is projected to surpass USD 2.62 Billion billion by 2032, growing at a healthy CAGR of 6.3%. Key factors driving this momentum include the surge in premium skincare solutions, the rising influence of e-commerce distribution channels, and a shift toward natural and organic formulations. Regional insights highlight that Asia-Pacific dominate the Anti Stretch Mark Products Market share, supported by strong consumer spending on personal care, while North America is emerging as the fastest-growing market, driven by urbanization, disposable income growth, and rising awareness among younger demographics.

Panthera Biopartnerscommercial clinical trials, has secured investment from leading private equity investor LDC to support its expansion plans and further enhance its clinical capabilities. Established in 2019 by co-founders Dr Ian Smith and Professor John Lyon, Panthera specialises in the recruitment of patients and running of Phase II and Phase III clinical trials. Its service offering spans trial planning, data collection and patient retention. Headquartered in Preston, Lancashire, the company operates six UK sites with two more planned and provides clinical trials for eight of the 12 largest pharmaceutical companies and all of the largest seven clinical research organisations (CROs).
Panthera Biopartners secures investment from LDC to accelerate expansion    Panthera Biopa…

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) The investigational device exemption (IDE) allows initiation of a global pivotal study designed to assess the safety and efficacy of the ARCIM System®, an implantable neurostimulation technology developed to address blood pressure instability after spinal cord injury (SCI). Managing blood pressure instability is a major unmet need after SCI, with a significant impact on cardiovascular health and quality of life. Approximately 20 leading neurorehabilit…

Extrovis AG, a global pharmaceutical company focused on research-driven innovation, and Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced the launch of Fluorouracil Cream, 0.5%, an authorized generic and therapeutic equivalent of Carac® (fluorouracil cream) 0.5%, in the US market, approved by the U.S. Food and Drug Administration (USFDA).
Extrovis AG and Dr. Reddy’s announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.                                        Extrovis AGBahnhof Park 46340, Baar, Switzerland Media Relations Conta…

The looming changes to the UK Apprenticeship Levy are causing ripples across industries. For the healthcare sector, which often relies on Level 7 apprenticeships to address leadership skills gaps and workforce challenges, these changes are particularly significant.
The looming changes to the UK Apprenticeship Levy are causing ripples across industries. For the healthcare sector, which often relies on Level 7 apprenticeships to address leadership skills gaps and workforce challenges, these changes are particularly significant. “With Levy funding for new Level 7 apprenticeship starters aged 22 and over ending in January 2026, healthcare organisations need to act swiftly to capitalise on current funding opportunities before the December cut-off,” explains Steven Hurst, Director of Corporate L…

Clinical trials are steadily becoming more complex, and the systems that support them must evolve in parallel to ensure efficiency, compliance, and data integrity. This complexity and change is most evident than in the way trial sponsors manage and collect clinical outcome assessment (COA) data. Once seen as a functional tool for tracking patient responses, electronic COA (eCOA) platforms are now seen as a foundational requirement for COA data collection and are often critical to trial success.
Clinical trials are steadily becoming more complex, and the systems that support them must evolve in parallel to ensure efficiency, compliance, and data integrity. This complexity and change is most evident than in the way trial sponsors manage and collect clinical outcome assessment (COA) data. Once…

The Culture Media Market, valued at USD 6.91 billion in 2023, is projected to reach USD 17.32 billion by 2032, growing at a CAGR of 10.9%. This surge is driven by advancements in biopharmaceutical production, stem cell research, and regenerative medicine. Key players are innovating with serum-free, chemically defined, and animal-component-free media to meet evolving industry demands. North America leads the Culture Media Market share, while Asia-Pacific emerges as the fastest-growing region. Explore market trends, growth drivers, and regional opportunities shaping the future of life sciences in our in-depth analysis.
The Culture Media Market is undergoing a dynamic transformation, responding to the surging needs of biopharmaceutical development, regenerative medicine, and academic research.…

In an era marked by rising energy costs, shifting regulations, and a growing demand for sustainable business practices, the cold storage industry stands at the crossroads of innovation and necessity. Energy efficiency is no longer a bonus—it’s a mandate. For businesses that rely on walk-in coolers and freezers, from restaurants and grocery stores to pharmaceutical labs and food distribution centers, future-ready refrigeration means embracing smarter, greener, and more efficient technologies.
The Future of Cold Storage: Innovations in Energy Efficiency By: Gian Carlo Alonso, President & CEO, Amerikooler  Why Energy Efficiency Matters Now More Than Ever In an era marked by rising energy costs, shifting regulations, and a growing demand for sustainable business practices, the cold sto…

Have you ever pondered over the ingredients list on your toothpaste tube and wondered what those scientific names mean, let alone their purpose? Among them, a trio of enzymes—Lysozyme, Glucose Oxidase, and Native Bovine Lactoperoxidase—play crucial roles in maintaining oral health.
Have you ever pondered over the ingredients list on your toothpaste tube and wondered what those scientific names mean, let alone their purpose? Among them, a trio of enzymes—Lysozyme, Glucose Oxidase, and Native Bovine Lactoperoxidase—play crucial roles in maintaining oral health.   Enzymes are essentially proteins that act as catalysts, speeding up biological reactions necessary for life. In toothpaste, enzymes like Lysozyme, Glucose Oxidase, and Native Bovine Lactoperoxidase serve to boost the product's e…

According to the latest Precision Medicine Market Report by Ameco Research, the Precision Medicine Market, valued at USD 98.3 billion in 2024, is projected to skyrocket to USD 365.5 billion by 2033, reflecting a robust CAGR of 15.8% during the 2025–2033 period.
According to the latest Precision Medicine Market Report by Ameco Research, the Precision Medicine Market, valued at USD 98.3 billion in 2024, is projected to skyrocket to USD 365.5 billion by 2033, reflecting a robust CAGR of 15.8% during the 2025–2033 period. This fast-paced growth underscores the transformation of healthcare—from traditional one-size-fits-all approaches to tailored therapies that hinge on patients’ genetic, environmental, and lifestyle profiles. The precision medicine market size and market outlook are reshaping c…

Native Protein Purification Market Size, Share, By Offering [Product (Chromatography Systems, Filtration Systems, Magnetic Beads and Resins, Reagent & Kits, and Others), Services (Protein Expression & Isolation, Research Outsourcing Services, Protein Production, Protein Purification, and Others)], Sources (Plant-Based Systems and Plant Tissues, Whole Blood, Serum, Human Plasma Systems, Animal Tissue, and Others), Technology (Chromatography, Electrophoresis, Ultrafiltration, Immunoprecipitation, and Others), Application (Biological Research, Drug Discovery and Development, Forensic Investigations, Diagnostics, Environmental Monitoring, and Others), End Users (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Diagnostic Laboratories, and Others), and Region - Trends, Analysis, and Forecast till 2035

Hackers know pharmaceutical robots are a lucrative avenue for priceless data. Pharmacies and hospitals must collaborate with manufacturers and analysts to formulate the most future-proof plans for medical robots. Communication will be the key to robust pharmaceutical tools that withstand any incoming onslaught from cybercriminals.
The medical sector has interwoven robotics into surgeries and research for decades, but they are becoming more essential and connected. From sensors to artificial intelligence capabilities, the amount of data and sensitive information they contain is a prime target for threat actors. Manufacturers and medical professionals must collaborate to create safe pharmaceutical robots to protect patients. Fortunately, many resources exist to combat concerns. How Are Robots…

The Smart Healthcare Fabrics Market is projected to reach USD 9,159.1 million by 2032, growing at a CAGR of 24.2% from 2024 to 2032. Discover market size, trends, regional insights, and growth drivers transforming medical textiles.
The Smart Healthcare Fabrics Market is redefining the future of healthcare by integrating cutting-edge textile engineering with medical innovation. These advanced fabrics are embedded with sensors, conductive yarns, and intelligent coatings, enabling them to monitor vital signs, regulate temperature, manage moisture, and even deliver targeted therapies. Designed for use in hospital bedding, patient gowns, wearable medical devices, and rehabilitation equipment, smart healthcare fabrics offer unparalleled benefits in patient comfort, infection control, and real-tim…

From sequence to 30 L and manufacturing scale, why outsourcing saves resources in the long run and makes economic sense.
Isomerase is a leading bioprocessing company that offers partners the ability to scale up their processes or projects from the lab to industrial manufacturing. Partners from various industries, including pharma, biotech, as well as food and ingredients, opt to work with our bioprocessing services when scaling. In this article, we provide an overview of what we offer, enabling you to make an informed decision when considering outsourcing.   What is microbial bioprocessing? Once a microbe and the product of interest have been optimised, by engineering the production strain and/or target sequence, the process needs to be scaled. Generating such a product within a livin…